SCHEMBL8316376

SCHEMBL8316376

NC[C@@H]1CC[C@@H](N)CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13456669 1.00
SCHEMBL14479181 1.00
SCHEMBL10019571 1.00
SCHEMBL31680384 1.00
SCHEMBL3634713 0.81 SLC6A2 (0.35)
SCHEMBL23373100 0.78
SCHEMBL12525053 0.78
SCHEMBL19050838 0.78
SCHEMBL22456311 0.78
SCHEMBL23705637 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230021684-A1 INHIBITORS OF THE MENIN-MLL INTERACTION SYNDAX PHARMACEUTICALS, INC. 2023-01-26 US disclosed
WO-2019194858-A1 MODULAR SYNTHESIS OF AMINOGLYCOSIDES ACHAOGEN, INC. (US) 2019-10-10 WO disclosed
WO-2019046126-A1 AMINOGLYCOSIDES AND USES THEREOF ACHAOGEN, INC. (US) 2019-03-07 WO disclosed
WO-2010030704-A2 ANTIBACTERIAL AMINOGLYCOSIDE ANALOGS ACHAOGEN, INC. (US) 2010-03-18 WO disclosed
WO-2004093821-A2 TREATMENT OF ANTHRAX INFECTION USING INHIBITORS OF LETHAL FACTOR PROTEASE ACTIVITY HAWAII BIOTECH, INC. (US) 2004-11-04 WO disclosed